Veru Inc. (VERU) - Dana dhuwit diétung saben saham

Simbol lan logo merek verupharma.com (VERU)

Veru Inc. is implementing breakthrough obesity treatment methods that preserve muscle tissue. Simultaneously, Veru Inc. is restructuring its profit model, reducing the share of the sexual health segment in favor of its oncology pipeline. The company's scientific potential relies on the development of microtubule inhibitors. Cash per share trends demonstrate liquidity management, where the 1.52 level reflects the current magnitude of the cash mass.

Veru Pharma - Dhuwit awis saben saham VERU (periode 04.07.2022 - 20.11.2026)

Rincian analitis perusahaan Veru (VERU)

- data dhuwit lan arus kas:
Ringkesan analisis perusahaan:VERU (Veru Corporation)
Produk asil prodhuksi verupharma.com

Veru Inc. occupies a promising niche by developing androgen receptor modulators to maintain muscle tone during obesity therapy. This indicator measures the proportion of liquid assets per security, reflecting the issuer's actual financial cushion. Investors analyze this balance to assess the company's resilience to cash flow gaps during the preparation of clinical releases. The current value of 1.52 determines the business's margin of safety. The dynamics of the cash position per share allow for the timely detection of excessive capital stagnation.

Analisis perusahaan pesaing

Dana dhuwit saben siji saham ONC (BeiGene Corp)|Dhuwit awis saben siji saham HALO (Halozyme Therapeutics, Inc.)|Dhuwit awis saben saham Revolution Medicines, Inc. (RVMD)|Dhuwit awis saben saham AAPG (ascentage.com)|CG Oncology Inc (CGON) - Cekelan dhuwit saben saham|URGN - Dana dhuwit saben saham|Bicara Bio - Dhuwit awis diétung saben siji saham|PSNL: Dhuwit awis saben saham|Dana dhuwit saben siji saham ERAS|Dhuwit awis saben siji saham DCTH|Cekelan dhuwit saben saham Y-mAbs Therapeutics Inc YMAB|Dhuwit awis saben saham AURA|CADL (Candel Therapeutics, Inc.) - Gunggung dhuwit awis saben saham|Dana dhuwit saben saham Accuray Inc ARAY|Dana dhuwit diétung saben saham SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Dhuwit awis saben saham|Cekelan dhuwit saben saham Citius Oncology|HURA: Dhuwit awis saben saham|Dhuwit awis saben lembar saham TARA (Protara)|FATE (fatetherapeutics.com) - Dhuwit awis saben saham|Cekelan dhuwit saben saham Aadi Bioscience WHWK|Dhuwit awis saben saham TCRX|CSBR - Cekelan dhuwit saben saham|XBiotech - Dhuwit awis saben siji saham|CEL-SCI Corporation (CVM) - Cekelan dhuwit saben saham|OSTX - Dana dhuwit saben saham|Cekelan dhuwit saben saham Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Dhuwit awis saben siji saham|ANL (Adlai Nortye Ltd) - Dana dhuwit saben saham|Dana dhuwit saben saham Tempest Therapeutics Corp|Dana dhuwit saben siji saham XLO (Xilio Therapeutics, Inc.)|Dhuwit awis saben saham RENB|MURA (Mural Oncology) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham KAPA (Kairos Pharma Ltd)|OKUR: Dana dhuwit saben siji saham|GDTC: Dhuwit awis saben siji saham|CRIS - Dhuwit awis saben saham|APLM: Dhuwit awis saben saham|Cekelan dhuwit saben saham tharimmune.com (THAR)|ADVB (Advanced Biomed Corp) - Dhuwit awis saben saham|Dhuwit awis saben saham Genprex Inc.|Dhuwit awis saben saham CLDI|Dhuwit awis saben siji saham Sunshine Biopharma, Inc. SBFM|Dhuwit awis saben saham XBIO (Xenetic Biosciences)|Gunggung dhuwit awis saben saham SLRX|PPBT - Dana dhuwit saben saham|AONC (aoncology.com) - Dana dhuwit saben siji saham|BGNE: Dhuwit awis saben saham|Checkpoint Therapeutics Inc (CKPT) - Dhuwit awis saben saham|ELEV (Elevation Oncology Inc.) - Dhuwit awis saben saham|icadmed.com (ICAD) - Dana dhuwit diétung saben saham|Dhuwit awis saben saham IKNA|NTBL (Notable Labs) - Gunggung dhuwit awis saben saham|Dhuwit awis saben saham VIRX (Viracta Therapeutics)|Dana dhuwit diétung saben saham MorphoSys AG (MOR)|NAYA Biosciences Corp - Dhuwit awis saben saham|Cekelan dhuwit saben saham ascentage.com